Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar;197(3):e63929.
doi: 10.1002/ajmg.a.63929. Epub 2024 Nov 13.

Optical Genome Mapping (OGM) Identifies Multiple Structural Variants in a Case With Atypical Phelan-McDermid Syndrome

Affiliations
Case Reports

Optical Genome Mapping (OGM) Identifies Multiple Structural Variants in a Case With Atypical Phelan-McDermid Syndrome

Erica L Macke et al. Am J Med Genet A. 2025 Mar.

Abstract

Here we describe a neonate exhibiting hypotonia, macrocephaly, renal cysts, and respiratory failure requiring tracheostomy and ventilator support. Genetic analysis via rapid genome sequencing (rGS) identified a loss on chromosome 4 encompassing polycystin-2 (PKD2) and a loss on chromosome 22 encompassing SH3 and Multiple Ankyrin Repeat Domains 3 (SHANK3), indicative of Phelan-McDermid syndrome. Further analysis via traditional karyotyping, Optical Genome Mapping (OGM), and PacBio long-read sequencing revealed a more complex landscape of chromosomal rearrangements in this individual, including a balanced 3;12 translocation, and an unbalanced 17;22 translocation. The proband's phenotypic presentation is thought to be the result of Phelan-McDermid syndrome and represents an expansion of the described phenotypes to include significant respiratory failure. This study underscores the challenges and importance of comprehensive genetic testing in elucidating complex presentations and highlights the need for complementary testing methods to overcome limitations in resolution.

Keywords: Phelan‐McDermid Syndrome; long‐read Sequencing; optical Genome Mapping; rapid Genome Sequencing.

PubMed Disclaimer

References

    1. Bergmann, C., L. M. Guay‐Woodford, P. C. Harris, S. Horie, D. J. M. Peters, and V. E. Torres. 2018. “Polycystic Kidney Disease.” Nature Reviews. Disease Primers 4, no. 1: 50.
    1. Burdeus‐Olavarrieta, M., A. San José‐Cáceres, A. García‐Alcón, J. González‐Peñas, P. Hernández‐Jusdado, and M. Parellada‐Redondo. 2021. “Characterisation of the Clinical Phenotype in Phelan‐McDermid Syndrome.” Journal of Neurodevelopmental Disorders 13, no. 1: 1–14.
    1. Cornec‐Le Gall, E., M. P. Audrézet, E. Renaudineau, et al. 2017. “PKD2‐Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.” American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 70, no. 4: 476–485.
    1. De Rubeis, S., P. M. Siper, A. Durkin, et al. 2018. “Delineation of the Genetic and Clinical Spectrum of Phelan‐McDermid Syndrome Caused by SHANK3 Point Mutations.” Molecular Autism 9, no. 1: 1–20.
    1. Ha, J. F., A. Ahmad, and M. M. Lesperance. 2016. “Clinical Characterization of Novel Chromosome 22q13 Microdeletions.” International Journal of Pediatric Otorhinolaryngology 95: 121–126.

Publication types

Supplementary concepts

LinkOut - more resources